// App-Quantinova.ai

P31.04 : Global Impact of COVID-19 on NSCLC Surgery: Initial Analysis of the CovidSurg-Cancer Study

Researchers

Presenter

  • A. Patel

Principal Investigators

  • J. Edwards

Medical Centers

  • Department of Thoracic Surgery, Sheffield/GB

  • Department of Thoracic Surgery, Cambridge/GB

  • Department of Thoracic Surgery, Sheffield/GB

  • Immunology and Immunotherapy, University of Birmingham, England/GB

  • Department of Thoracic Surgery, Sheffield/GB

  • Department of Thoracic Surgery, Plymouth/GB

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Coronavirus disease

  • Solid malignancies

  • Non Small Cell Lung cancer

  • Acute lung injury

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A